Diagnosis of biphenotypic acute leukemia: A paradigmatic approach

Xianfeng Frank Zhao, Ivana Gojo, Teresa York, Yi Ning, Maria R. Baer

Research output: Contribution to journalArticle

Abstract

Biphenotypic acute leukemia (BAL), or acute leukemia with a single population of blasts coexpressing markers of two different lineages, is a rare clinical entity. To define BAL, a scoring system was proposed by the European Group of Immunological Markers for Leukemias (EGIL) in 1995. However, increasing evidence suggests that this system has limitations, as acknowledged by the 2008 World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues. Although substantially improved in relation to the EGIL, the new WHO Classification is still not optimal for guiding the clinical management of patients with BAL. We propose a new paradigmatic approach to defining BAL based on recent clinical studies of BAL and advances in immunologic marker definition and cytogenetics, and applied our new approach to 8 cases of "BAL" among a cohort of 742 new acute leukemias in our Cancer Center. By our new criteria, 6 cases were reclassified as acute lymphoblastic leukemia (ALL), while only 2 were still classified as BAL. Our approach is also supported by analyses of the BAL cases previously reported by other institutions.

Original languageEnglish (US)
Pages (from-to)75-86
Number of pages12
JournalInternational Journal of Clinical and Experimental Pathology
Volume3
Issue number1
StatePublished - 2010
Externally publishedYes

Fingerprint

Biphenotypic Acute Leukemia
Leukemia
Lymphoid Tissue
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Cytogenetics
Neoplasms
Biomarkers

Keywords

  • ALL
  • AML
  • Biphenotypic acute leukemia
  • classification
  • EGIL

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Diagnosis of biphenotypic acute leukemia : A paradigmatic approach. / Zhao, Xianfeng Frank; Gojo, Ivana; York, Teresa; Ning, Yi; Baer, Maria R.

In: International Journal of Clinical and Experimental Pathology, Vol. 3, No. 1, 2010, p. 75-86.

Research output: Contribution to journalArticle

Zhao, Xianfeng Frank ; Gojo, Ivana ; York, Teresa ; Ning, Yi ; Baer, Maria R. / Diagnosis of biphenotypic acute leukemia : A paradigmatic approach. In: International Journal of Clinical and Experimental Pathology. 2010 ; Vol. 3, No. 1. pp. 75-86.
@article{b794c87945c543b280dd2f95c7bfa090,
title = "Diagnosis of biphenotypic acute leukemia: A paradigmatic approach",
abstract = "Biphenotypic acute leukemia (BAL), or acute leukemia with a single population of blasts coexpressing markers of two different lineages, is a rare clinical entity. To define BAL, a scoring system was proposed by the European Group of Immunological Markers for Leukemias (EGIL) in 1995. However, increasing evidence suggests that this system has limitations, as acknowledged by the 2008 World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues. Although substantially improved in relation to the EGIL, the new WHO Classification is still not optimal for guiding the clinical management of patients with BAL. We propose a new paradigmatic approach to defining BAL based on recent clinical studies of BAL and advances in immunologic marker definition and cytogenetics, and applied our new approach to 8 cases of {"}BAL{"} among a cohort of 742 new acute leukemias in our Cancer Center. By our new criteria, 6 cases were reclassified as acute lymphoblastic leukemia (ALL), while only 2 were still classified as BAL. Our approach is also supported by analyses of the BAL cases previously reported by other institutions.",
keywords = "ALL, AML, Biphenotypic acute leukemia, classification, EGIL",
author = "Zhao, {Xianfeng Frank} and Ivana Gojo and Teresa York and Yi Ning and Baer, {Maria R.}",
year = "2010",
language = "English (US)",
volume = "3",
pages = "75--86",
journal = "International Journal of Clinical and Experimental Pathology",
issn = "1936-2625",
publisher = "e-Century Publishing Corporation",
number = "1",

}

TY - JOUR

T1 - Diagnosis of biphenotypic acute leukemia

T2 - A paradigmatic approach

AU - Zhao, Xianfeng Frank

AU - Gojo, Ivana

AU - York, Teresa

AU - Ning, Yi

AU - Baer, Maria R.

PY - 2010

Y1 - 2010

N2 - Biphenotypic acute leukemia (BAL), or acute leukemia with a single population of blasts coexpressing markers of two different lineages, is a rare clinical entity. To define BAL, a scoring system was proposed by the European Group of Immunological Markers for Leukemias (EGIL) in 1995. However, increasing evidence suggests that this system has limitations, as acknowledged by the 2008 World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues. Although substantially improved in relation to the EGIL, the new WHO Classification is still not optimal for guiding the clinical management of patients with BAL. We propose a new paradigmatic approach to defining BAL based on recent clinical studies of BAL and advances in immunologic marker definition and cytogenetics, and applied our new approach to 8 cases of "BAL" among a cohort of 742 new acute leukemias in our Cancer Center. By our new criteria, 6 cases were reclassified as acute lymphoblastic leukemia (ALL), while only 2 were still classified as BAL. Our approach is also supported by analyses of the BAL cases previously reported by other institutions.

AB - Biphenotypic acute leukemia (BAL), or acute leukemia with a single population of blasts coexpressing markers of two different lineages, is a rare clinical entity. To define BAL, a scoring system was proposed by the European Group of Immunological Markers for Leukemias (EGIL) in 1995. However, increasing evidence suggests that this system has limitations, as acknowledged by the 2008 World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues. Although substantially improved in relation to the EGIL, the new WHO Classification is still not optimal for guiding the clinical management of patients with BAL. We propose a new paradigmatic approach to defining BAL based on recent clinical studies of BAL and advances in immunologic marker definition and cytogenetics, and applied our new approach to 8 cases of "BAL" among a cohort of 742 new acute leukemias in our Cancer Center. By our new criteria, 6 cases were reclassified as acute lymphoblastic leukemia (ALL), while only 2 were still classified as BAL. Our approach is also supported by analyses of the BAL cases previously reported by other institutions.

KW - ALL

KW - AML

KW - Biphenotypic acute leukemia

KW - classification

KW - EGIL

UR - http://www.scopus.com/inward/record.url?scp=77449114378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77449114378&partnerID=8YFLogxK

M3 - Article

C2 - 19918331

AN - SCOPUS:77449114378

VL - 3

SP - 75

EP - 86

JO - International Journal of Clinical and Experimental Pathology

JF - International Journal of Clinical and Experimental Pathology

SN - 1936-2625

IS - 1

ER -